Ticker LaunchRegulation A · Tier 2
Starpax Biopharma Inc.
Starpax Biopharma Inc. filed a Tier 2 Regulation A offering statement (Form 1-A) on Feb 9, 2023 for up to $24M at $6.00 per security. The SEC qualified the offering on Sep 11, 2023.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $24M
- Offer price
- $6.00
- Security type
- Equity (common or preferred stock)
- Filed
- Feb 9, 2023
- Qualified
- Sep 11, 2023
- Industry
- Pharmaceutical Preparations
- State
- Quebec, Canada
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Amount raised, from the exit report (Form 1-Z)
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
Other qualified Biotech & pharma Reg A offerings
- CancerVAX, Inc.Mar 22, 2024 · $5M
- IntelGenx Technologies Corp.Feb 16, 2024 · $20M
- SciMar Ltd.Dec 21, 2023 · $55M
- CancerVAX, Inc.May 30, 2023 · $10M
- Sibannac, Inc.Mar 15, 2023 · $6M
- Algernon Neuroscience Inc.Mar 8, 2023 · $10M